We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-13.55%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$488M
AUM Growth
-$122M
Cap. Flow
-$46M
Cap. Flow %
-9.42%
Top 10 Hldgs %
12.26%
Holding
885
New
278
Increased
177
Reduced
136
Closed
293

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$7.96M
2
MSFT icon
Microsoft
MSFT
+$6.24M
3
EL icon
Estee Lauder
EL
+$5.96M
4
CSCO icon
Cisco
CSCO
+$5.04M
5
WBA
Walgreens Boots Alliance
WBA
+$4.16M

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Consumer Discretionary 16.56%
3 Healthcare 14.16%
4 Industrials 11.69%
5 Consumer Staples 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COHR icon
101
Coherent
COHR
$51.5B
$1.28M 0.26%
39,551
+33,451
+548% +$1.25M
CF icon
102
CF Industries
CF
$18.6B
$1.27M 0.26%
29,100
+23,360
+407% +$1.1M
JBHT icon
103
JB Hunt Transport Services
JBHT
$26.2B
$1.26M 0.26%
13,575
-10,725
-44% -$1.14M
CINF icon
104
Cincinnati Financial
CINF
$28.5B
$1.26M 0.26%
+16,300
New +$1.27M
ATHN
105
DELISTED
Athenahealth, Inc.
ATHN
$1.26M 0.26%
+9,562
New +$1.22M
COF icon
106
Capital One
COF
$127B
$1.26M 0.26%
16,619
+13,900
+511% +$1.2M
PEP icon
107
PepsiCo
PEP
$191B
$1.25M 0.26%
+11,305
New +$1.27M
AME icon
108
Ametek
AME
$55.2B
$1.25M 0.26%
+18,400
New +$1.32M
PG icon
109
Procter & Gamble
PG
$347B
$1.24M 0.25%
+13,511
New +$1.21M
CE icon
110
Celanese
CE
$4.9B
$1.23M 0.25%
13,657
+400
+3% +$39.2K
BRK.A icon
111
Berkshire Hathaway Class A
BRK.A
$1.07T
$1.22M 0.25%
+4
New +$1.25M
VOD icon
112
Vodafone
VOD
$36.5B
$1.22M 0.25%
+63,400
New +$1.27M
RHI icon
113
Robert Half
RHI
$4.04B
$1.22M 0.25%
21,329
-12,200
-36% -$749K
IQV icon
114
IQVIA
IQV
$35.3B
$1.22M 0.25%
+10,494
New +$1.27M
FDS icon
115
Factset
FDS
$9.5B
$1.21M 0.25%
+6,052
New +$1.33M
CTAS icon
116
Cintas
CTAS
$84.5B
$1.21M 0.25%
+28,800
New +$1.29M
P
117
Everpure Inc
P
$24.4B
$1.21M 0.25%
75,200
+22,400
+42% +$441K
ON icon
118
ON Semiconductor
ON
$34.2B
$1.2M 0.25%
72,900
+57,100
+361% +$988K
MRVL icon
119
Marvell Technology
MRVL
$170B
$1.2M 0.25%
74,100
-35,300
-32% -$585K
PRKS icon
120
United Parks & Resorts
PRKS
$2.1B
$1.2M 0.25%
54,200
-47,600
-47% -$1.27M
ZBH icon
121
Zimmer Biomet
ZBH
$17.9B
$1.19M 0.24%
11,845
-1,545
-12% -$174K
ESIO
122
DELISTED
Electro Scientific Industries
ESIO
$1.19M 0.24%
39,795
+4,601
+13% +$114K
OKTA icon
123
Okta
OKTA
$24.1B
$1.19M 0.24%
18,627
-23,800
-56% -$1.41M
AZN icon
124
AstraZeneca
AZN
$263B
$1.19M 0.24%
+15,607
New +$1.22M
SEND
125
DELISTED
SendGrid, Inc.
SEND
$1.18M 0.24%
27,382
+17,100
+166% +$658K

Similar funds

Bayesian Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Bayesian Capital Management held 885 positions worth $488M, down 20% from $611M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bayesian Capital Management withdrew a net $46M in Q4 2018, closing 293 positions and reducing 136 holdings. Its most notable exit was Lowe's Companies, an estimated $6.56M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Nike worth $7.89M.

  • Bayesian Capital Management's largest Q4 2018 buy was Nike: 106,400 shares worth $7.89M.
  • Bayesian Capital Management added most to Microsoft in Q4 2018, an estimated $6.24M increase.
  • Bayesian Capital Management's biggest Q4 2018 reduction was lululemon athletica, cutting an estimated $6.86M.
  • Bayesian Capital Management fully exited Lowe's Companies in Q4 2018, selling an estimated $6.56M.
  • Bayesian Capital Management's ten largest holdings make up 12% of its $488M portfolio in Q4 2018.
  • Bayesian Capital Management opened 278 new positions and closed 293 in Q4 2018.
  • Bayesian Capital Management's portfolio value fell 20% quarter-over-quarter to $488M.

Based on Bayesian Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.